This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2022 Aug;39(4):543.

doi: 10.1007/s10719-022-10075-7.

Correction to: Sialidase NEU3 and its pathological significance

Taeko Miyagi¹, Koji Yamamoto²

Affiliations

Affiliations

¹ Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan. miyagi-ta@nifty.com.
² Faculty of Health and Medical Care, Saitama Medical University, Moroyama, Saitama, Japan.

PMID: 35834088
DOI: 10.1007/s10719-022-10075-7

Published Erratum

Correction to: Sialidase NEU3 and its pathological significance

Taeko Miyagi et al. Glycoconj J. 2022 Aug.

. 2022 Aug;39(4):543.

doi: 10.1007/s10719-022-10075-7.

Authors

Taeko Miyagi¹, Koji Yamamoto²

Affiliations

¹ Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan. miyagi-ta@nifty.com.
² Faculty of Health and Medical Care, Saitama Medical University, Moroyama, Saitama, Japan.

PMID: 35834088
DOI: 10.1007/s10719-022-10075-7

No abstract available

PubMed Disclaimer

Erratum for

Sialidase NEU3 and its pathological significance.
Miyagi T, Yamamoto K. Miyagi T, et al. Glycoconj J. 2022 Oct;39(5):677-683. doi: 10.1007/s10719-022-10067-7. Epub 2022 Jun 8. Glycoconj J. 2022. PMID: 35675020 Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer